Global Porcine Vaccine Market
Veterinary Healthcare

Overview Of The Porcine Vaccine Market 2024-2033: Growth And Major Players Analysis

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The porcine vaccine market has shown robust growth over recent years and is expected to continue this trend. This blog delves into the factors driving this growth, key trends, and future projections for the market.

Recent Market Growth and Projections

  • Market Size and Growth Rate:
    • The porcine vaccine market grew from $1.74 billion in 2023 to $1.91 billion in 2024, with a CAGR of 9.5%.
    • By 2028, the market is projected to reach $2.73 billion, growing at a CAGR of 9.4%.
  • Historical Growth Drivers:
    • Disease outbreaks and control measures.
    • Global increase in pork consumption.
    • Intensification of pig farming.
    • Government initiatives for disease control.
    • Awareness and education programs.

Future Market Growth Drivers

  • Global Expansion of Pig Farming:
    • Increasing demand for pork worldwide drives expansion of pig farming operations.
  • Rising Disease Challenges:
    • New and recurring disease threats necessitate advanced vaccine solutions.
  • Stringent Regulations and Compliance:
    • Government regulations on animal health and safety push for effective vaccination programs.
  • Technological Advancements in Vaccine Development:
    • Innovations in biotechnology and genomic approaches enhance vaccine efficacy and customization.
  • Global Trade and Disease Risk Mitigation:
    • Global pork trade requires robust disease control measures to prevent outbreaks.

View More On The Porcine Vaccine Market Report 2024 –

Trends Shaping the Future of Porcine Vaccines

  • Customization of Vaccines for Regional Challenges:
    • Tailoring vaccines to address specific regional disease threats.
  • Integration of Biotechnology in Vaccine Development:
    • Utilizing biotech for more precise and effective vaccine formulations.
  • Rising Concerns About Zoonotic Diseases:
    • Increased focus on preventing diseases that can transfer from animals to humans.
  • Application of Genomic Approaches in Vaccine Design:
    • Genomic technologies aid in developing more targeted and effective vaccines.
  • Growing Investments in Research and Development:
    • Increased funding for innovative vaccine research and development.

Surging Swine Disease Infections Fuel Growth

  • Swine Disease Infections:
    • Rising infections, such as swine influenza (swine flu), drive demand for vaccines.
    • Swine influenza is commonly caused by the type A influenza virus, leading to frequent outbreaks.
  • Vaccine Mechanism:
    • Porcine vaccines stimulate the pig’s immune system, preparing it to fight pathogens and prevent sickness.
  • Case Example:
    • In December 2021, European countries reported 1,844 outbreaks of African Swine Fever (ASF), highlighting the need for effective vaccines.

Key Players in the Porcine Vaccine Market

  • Major Companies:
    • Bayer AG
    • Sanofi Pasteur Inc.
    • Eli Lilly and Company
    • Boehringer Ingelheim International GmbH
    • Zoetis Inc.
    • Arko Laboratories Limited
    • Merck Animal Health
    • Elanco Animal Health Incorporated
    • Ceva Santé Animale
    • Huvepharma Inc.

Innovative Advancements in Swine Health

  • Flex ParvoPRRS Vaccine:
    • Launched by Boehringer Ingelheim in September 2021, it combines protection against PRRS and Porcine Parvovirus.
    • Designed to improve reproductive health and productivity in pigs, supporting mass vaccination strategies.

Strategic Acquisitions and Market Expansion

  • Vaxxinova International BV Acquisition of Newport Labs:
    • In October 2021, Vaxxinova International BV acquired Newport Labs to enhance its product portfolio and expand its presence in the swine and cattle disease market.

Market Segmentation

  • By Technology:
    • Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines.
  • By Disease Indication:
    • Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, PRRSV, PCVAD, Other Disease Indications.
  • By End User:
    • Veterinary Hospitals, Hog or Pig Production Farms.

Regional Market Insights

  • North America:
    • North America was the largest region in the porcine vaccine market in 2023.


The porcine vaccine market is set for significant growth, driven by increasing disease challenges, technological advancements, and a global expansion of pig farming. With continuous innovations and strategic acquisitions, the market is well-positioned to address the evolving needs of swine health management.

Request A Sample Of The Global Porcine Vaccine Market Report 2024: